Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: A 5-year cause-of-death analysis of the FAST-MI 2005 registry

European Heart Journal

Volumn 35, Issue 2, 2014, Pages 116-122

  Bougouin, Wulfran ^a,b,c   Marijon, Eloi ^a,b,c   Puymirat, Etienne ^a,b,c   Defaye, Pascal ^d   Celermajer, David S ^e   Le Heuzey, Jean Yves ^a,b   Boveda, Serge ^f   Kacet, Salem ^g   Mabo, Philippe ^h,i   Barnay, Claude ^j   Da Costa, Antoine ^k   Deharo, Jean Claude ^l   Daubert, Jean Claude ^h,i   Ferrières, Jean ^m   Simon, Tabassome ^n,o   Danchin, Nicolas ^a,b,c  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY OF SYDNEY   (Australia)

^f CLINIQUE PASTEUR   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h RENNES UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITÉ DE RENNES 1   (France)

^j General Hospital   (France)

^k UNIVERSITÉ JEAN MONNET   (France)

^l TIMONE HOSPITAL   (France)

^m CHU RANGUEIL   (France)

ⁿ HÔPITAL SAINT ANTOINE   (France)

^o SORBONNE UNIVERSITÉ   (France)

more..

Author keywords

Acute coronary syndrome; Implantable cardioverter defibrillator; Prognosis; Sudden death; Ventricular fibrillation

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; FRANCE; HEART VENTRICLE FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; SUDDEN CARDIAC DEATH; SURVIVAL RATE; SURVIVOR; YOUNG ADULT;

ACUTE CORONARY SYNDROME; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PROGNOSIS; SUDDEN DEATH; VENTRICULAR FIBRILLATION;

DEATH, SUDDEN, CARDIAC; EPIDEMIOLOGIC METHODS; FRANCE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; VENTRICULAR FIBRILLATION;

EID: 84892648328     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht453     Document Type: Article

References (43)

1. Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012;344:d8059.
2. Puymirat E, SimonT, Steg PG, Schiele F,Guéret P, Blanchard D, Khalife K, Goldstein P, Cattan S, Vaur L, Cambou J-P, Ferrières J, Danchin N. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA 2012;308:998-1006.
3. Henriques JPS, Gheeraert PJ, Ottervanger JP, de Boer M-J, Dambrink J-HE, Gosselink ATM, van 't Hof AWJ, Hoorntje JCA, Suryapranata H, Zijlstra F. Ventricular fibrillation in acute myocardial infarction before and during primary PCI. Int J Cardiol 2005;105:262-266.
4. Mehta RH, Starr AZ, Lopes RD,HochmanJS, Widimsky P, Pieper KS, ArmstrongPW, Granger CB. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA 2009;301:1779-1789.
5. Al-Khatib SM, Granger CB, HuangY, Lee KL, Califf RM, Simoons ML, ArmstrongPW, Van deWerf F, White HD, Simes RJ, Moliterno DJ, Topol EJ, Harrington RA. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation 2002;106:309-312.
6. Mehta RH, Harjai KJ, Grines L, Stone GW, Boura J, Cox D, O'NeillW, Grines CL. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. J Am Coll Cardiol 2004;43:1765-1772.
7. Piccini JP, Berger JS, Brown DL. Early sustained ventricular arrhythmias complicating acute myocardial infarction. Am J Med 2008;121:797-804.
8. JensenGV, Torp-Pedersen C, Hildebrandt P, Kober L, Nielsen FE, Melchior T, JoenT, Andersen PK. Does in-hospital ventricular fibrillation affect prognosis after myocardial infarction? Eur Heart J 1997;18:919-924.
9. Volpi A, Cavalli A, Santoro L, Negri E. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction-results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database.Am J Cardiol 1998;82:265-271.
10. Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO investigators. Circulation 1998;98:2567-2573.
11. Piccini JP, White JA, Mehta RH, Lokhnygina Y, Al-Khatib SM, Tricoci P, Pollack CV Jr, Montalescot G, Van deWerf F, Gibson CM, Giugliano RP, Califf RM, Harrington RA, Newby LK. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation 2012;126:41-49.
12. Mehta RH, Yu J, Piccini JP, Tcheng JE, Farkouh ME, Reiffel J, Fahy M, Mehran R, Stone GW. Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI trial). Am J Cardiol 2011;109:805-812.
13. De Jong JSSG, Marsman RF, Henriques JPS, Koch KT, de Winter RJ, Tanck MWT, WildeAAM,Dekker LRC.Prognosisamong survivorsof primary ventricularfibrillation in the percutaneous coronary intervention era. Am Heart J 2009;158:467-472.
14. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA/HRS 2008Guidelines for Device-based Therapy of Cardiac RhythmAbnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350-e408.
15. Friedlander Y, Siscovick DS, Weinmann S, Austin MA, Psaty BM, Lemaitre RN, Arbogast P, Raghunathan TE, Cobb LA. Family history as a risk factor for primary cardiac arrest. Circulation 1998;97:155-160.
16. Jouven X, Desnos M, Guerot C, Ducimetière P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation 1999;99:1978-1983.
17. Wyse DG, Friedman PL, Brodsky MA, Beckman KJ, Carlson MD, Curtis AB, Hallstrom AP, Raitt MH, Wilkoff BL, Greene HL, others. Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. J Am Coll Cardiol 2001;38:1718-1724.
18. Dekker LRC, Bezzina CR, Henriques JPS, Tanck MW, Koch KT, Alings MW, Arnold AER, de Boer M-J, Gorgels APM, Michels HR, Verkerk A, Verheugt FWA, Zijlstra F, Wilde AAM. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation 2006;114:1140-1145.
19. Kaikkonen KS, Kortelainen M-L, Linna E, Huikuri HV. Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation 2006;114:1462-1467.
20. Matsue Y, Suzuki M, Nishizaki M, Hojo R, Hashimoto Y, Sakurada H. Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. J Am Coll Cardiol 2012;60:908-913.
21. BougouinW, Karam N, Marijon E. Letter regarding article by Piccini et al, Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segmentelevation acute coronary syndromes. Circulation 2013;127:e633.
22. CambouJ-P, SimonT, Mulak G, BatailleV, Danchin N. The French registry of acute ST elevation or non-ST-elevation myocardial infarction (FAST-MI): study design and baseline characteristics. Arch Mal Coeur Vaiss 2007;100:524-534.
23. Danchin N, Coste P, Ferrières J, Steg P-G, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, Sans P, Charbonnier B, Eltchaninoff H, Guéret P, Khalife K, Asseman P, Puel J, Goldstein P, Cambou J-P, Simon T. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the French registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008;118:268-276.
24. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982; 65:457-464.
25. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-808.
26. Deo R, Albert CM. Epidemiology and genetics of sudden cardiac death. Circulation 2012;125:620-637.
27. Zipes DP,Wellens HJJ. Sudden cardiac death. Circulation 1998;98:2334-2351.
28. Solomon SD, Zelenkofske S, McMurray JJV, Finn PV, Velazquez E, ErtlG, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352:2581-2588.
29. Adabag AS, Therneau TM, Gersh BJ,Weston SA, Roger VL. Sudden death after myocardial infarction. JAMA 2008;300:2022-2029.
30. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ. Prophylactic use of an implantable cardioverter- defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-2488.
31. Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D, Kornacewicz-Jach Z, Sredniawa B, Lupkovics G, Hofgärtner F, others. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009;361:1427-1436.
32. Dorian P, Hohnloser SH, Thorpe KE, Roberts RS, Kuck K-H, Gent M, Connolly SJ. Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the defibrillation in acute myocardial infarction trial (DINAMIT). Circulation 2010;122:2645-2652.
33. Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, Kapa S, Kremers MS, Lindsay BD, Stevenson LW. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/ SCMR 2013 appropriate use criteria for implantable cardioverterdefibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 2013;61:1318-1368.
34. Ruiz-Bailén M, Aguayo de Hoyos E, Ruiz-Navarro S, Issa-Khozouz Z, Reina-Toral A, D́az-Castellanos MA, Rodr?́guez-Garća J-J, Torres-Ruiz JM, Cárdenas-Cruz A, Camacho-V́ctor A. Ventricular fibrillation in acute myocardial infarction in Spanish patients: results of the ARIAM database. Crit Care Med 2003;31:2144-2151.
35. Henkel DM, Witt BJ, Gersh BJ, Jacobsen SJ, Weston SA, Meverden RA, Roger VL. Ventricular arrhythmias after acute myocardial infarction: a 20-year community study. Am Heart J 2006;151:806-812.
36. Al-Khatib SM, Stebbins AL, Califf RM, Lee KL, Granger CB, White HD, ArmstrongPW, Topol EJ, OhmanEM. Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial. Am Heart J 2003;145:515-521.
37. Drew BJ, Califf RM, Funk M, Kaufman ES, Krucoff MW, Laks MM, Macfarlane PW, Sommargren C, Swiryn S, Van Hare GF, American Heart Association, Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young. Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-care Nurses. Circulation 2004;110:2721-2746.
38. Pouleur A-C, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL, Maggioni AP, Kober L, Califf RM, McMurray JJV, PfefferMA, Solomon SD; for theVALIANTInvestigators. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation 2010;122:597-602.
39. Sager PT, Perlmutter RA, Rosenfeld LE, McPherson CA,Wackers FJ, Batsford WP. Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation. J Am Coll Cardiol 1988;12:19-24.
40. ZipesDP,CammAJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc J-J, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for management of patients With ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e385-e484.
41. Yan G-X. Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia. Circulation 2004;110:1036-1041.
42. Wijnmaalen AP, Schalij MJ, von der Thusen JH, Klautz RJM, Zeppenfeld K. Early reperfusion during acute myocardial infarction affects ventricular tachycardia characteristics and the chronic electroanatomic and histological substrate. Circulation 2010;121:1887-1895.
43. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation 2012;125:1043-1052.